Intel Lobbies For Home-Based Medical Technology
This article was originally published in The Gray Sheet
Executive Summary
Many members of Congress working on health care reform do not appreciate the full potential of technology to make the U.S. health care system more cost-effective, according Eric Dishman, director of Health Innovation and Policy for Intel's Digital Health Group
You may also be interested in...
Intel’s First Home-Monitor Device Clears FDA, Will Launch This Year
Computer chip giant Intel expects to get into the U.S. medical device market later this year with the Health Guide home chronic condition management tool
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.